A plain language summary of NALIRIFOX compared with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer (NAPOLI 3)
Future Oncology | February 12, 2025 | Volume: 21 | Issue: 7 | Pages: 765-774
10.1080/14796694.2025.2458458
| PMID 39935331